Proteasome inhibitor-associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature.

HOME
>
論文・技術情報
>
Proteasome inhibitor-associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature.

アブストラクト
ジャーナル名	American journal of hematology
Pubmed追加日	2020/4/16
投稿者	Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S Christopher; Kanapuru, Bindu; Gormley, Nicole; Waldron, Peter E
組織名	Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food;and Drug Administration, Silver Spring, Maryland, USA.;Division of Hematologic Malignancies, Office of Oncologic Diseases, U.S. Food and;Drug Administration, Silver Spring, Maryland, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/32291777/